Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Slides:

Advertisements

Similar presentations

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Advertisements

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of.

Shin-Ichi Nishikawa, MD, PhD

Kiwi fruit allergy: A new birch pollen–associated food allergy

Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis Andrzej Bożek, MD, PhD, Krzysztof Kołodziejczyk, MD, PhD, Jerzy Jarząb,

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Kiwi fruit allergy: A new birch pollen–associated food allergy

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults Peter S. Creticos, MD, Jennifer Maloney,

Ulf Darsow, MD, Dieter Vieluf, MD, Johannes Ring, MD, PhD

Erika Lerch, MD, Ulrich R. Müller, MD

Rosa Codina, PhD, Richard F. Lockey, MD

Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma

The effect of omalizumab on nasal allergic inflammation

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Is 9 more than 2 also in allergic airway inflammation?

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of.

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity Csaba Szalai, PhD, Gergely T. Kozma, BSc, Adrienne.

Allergy to eggs from duck and goose without sensitization to hen egg proteins Belén Añíbarro, MD, F.Javier Seoane, MD, Concepción Vila, MD, Manuel Lombardero,

Elephantiasis nostras: A case report

Conjunctivitis medicamentosa

Side effects of inhaled corticosteroids

Practice Notes from the AAAAI

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.

Reply Journal of Allergy and Clinical Immunology

Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb

Phillip Lieberman, MD, Michael Tankersley, MD

Robert A. Wood, MD, Wanda Phipatanakul, MD, Robert G

Legends in allergy: Philip S. Norman and Lawrence M

A review of the current guidelines for allergic rhinitis and asthma

Early decreases in blood eosinophil levels with reslizumab

News & Notes Journal of Allergy and Clinical Immunology

Allergens in school dust: II

Direct exposure of carpets to sunlight can kill all mites

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma Oliver.

Allergen-specific immunotherapy with recombinant grass pollen allergens Marek Jutel, MD, Lothar Jaeger, MD, Roland Suck, PhD, Hanns Meyer, Dipl Math,

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.

Patterns of pollen cross-allergenicity

Molecular virology and immunology of HIV infection

Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis Stephen R. Durham,

News & Notes Journal of Allergy and Clinical Immunology

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic.

Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand’s disease in a family cluster Pramod S. Kelkar, MD, Rosa M. Ten,

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Emma Broadfield, MRCP, Tricia M

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years Ronald Dahl, MD,

Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet Stephen.

Piotr Kuna, MD, Jadwiga Kaczmarek, MD, Maciej Kupczyk, MD

Seasonal intestinal inflammation in patients with birch pollen allergy

Practice Notes from the AAAI

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,

Determinants of systemic manifestations of food allergy

Footnotes1 Journal of Allergy and Clinical Immunology

Evelyn Farinas, RPh, MGA, Peter Honig, MD

Fiftieth Annual Meeting of the American Academy of Allergy and Immunology: Anaheim, California, March 1994 Lawrence M. Lichtenstein, MD, PhD Journal.

News & Notes Journal of Allergy and Clinical Immunology

Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo- controlled study Lone Nielsen, MD, Claus R. Johnsen, MD, Holger.

Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Natural history of cow’s milk allergy

A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis Ebba Hedén Blomqvist,

Presentation transcript:

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle Löwhagen, MD, PhD, Sabina Rak, MD, PhD Journal of Allergy and Clinical Immunology Volume 109, Issue 5, Pages 777-783 (May 2002) DOI: 10.1067/mai.2002.123868 Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 1 Mean daily symptom score values in active and placebo groups, each expressed as AUC in relation to the pollen curve during the 1997 season. The differences in AUC between groups were significant (P = .05, counted for the whole season). Journal of Allergy and Clinical Immunology 2002 109, 777-783DOI: (10.1067/mai.2002.123868) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 2 Mean daily symptom score values in active and placebo groups, each expressed as AUC in relation to the pollen curve during the 1998 season. The differences in AUC between groups were significant (P = .005, counted for the whole season). Peak value for the pollen season was 5300 pollen grains/m3, which is not depicted in the figure. Journal of Allergy and Clinical Immunology 2002 109, 777-783DOI: (10.1067/mai.2002.123868) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 3 Mean daily medication score values in active and placebo groups, each expressed as AUC in relation to the pollen curve during the 1997 pollen season. The differences in AUC between groups were significant (P = .004, counted for the whole season). Journal of Allergy and Clinical Immunology 2002 109, 777-783DOI: (10.1067/mai.2002.123868) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 4 Mean daily medication score values in active and placebo groups, each expressed as AUC in relation to the pollen curve during the 1998 pollen season. The differences in AUC between groups were significant (P = .004, counted for the whole season). Peak value for the pollen season was 5300 pollen grains/m3, which is not depicted in the figure. Journal of Allergy and Clinical Immunology 2002 109, 777-783DOI: (10.1067/mai.2002.123868) Copyright © 2002 Mosby, Inc. Terms and Conditions